Semaglutide, a popular drug for diabetes and weight loss, might reduce the risk of Alzheimer’s disease in people with type 2 diabetes. This effect is consistent across different groups, including those varying by obesity status, gender, and age

3 weeks ago 18
Semaglutide, a popular drug for diabetes and weight loss, might reduce the risk of Alzheimer’s disease in people with type 2 diabetes. This effect is consistent across different groups, including those varying by obesity status, gender, and age submitted by /u/giuliomagnifico
[link] [comments]
Read Entire Article
  1. Homepage
  2. Science
  3. Semaglutide, a popular drug for diabetes and weight loss, might reduce the risk of Alzheimer’s disease in people with type 2 diabetes. This effect is consistent across different groups, including those varying by obesity status, gender, and age

Related

Researchers developed a new supramolecular polymer based plastic. It is as strong as conventional plastics and biodegradable, and breaks down in seawater. It can help reduce harmful microplastic pollution that accumulates in oceans and soil and eventually enters the food chain.

Researchers developed a new supramolecular polymer based pla...

1 hour ago 0
New study estimates that a 1-meter sea level rise by 2100 would affect over 14 million people and $1 trillion worth of property along the Southeast Atlantic coast, from Norfolk, Virginia, to Miami, Florida. The scale of these interconnected hazards is much greater than anticipated

New study estimates that a 1-meter sea level rise by 2100 wo...

4 hours ago 1
Women with a history of endometriosis and uterine fibroids might have an increased long-term risk of premature death, according to a study of 110,000 women aged 25-32. Endometriosis was associated with a 31% higher risk of premature death – largely driven by deaths from gynecological cancers.

Women with a history of endometriosis and uterine fibroids m...

5 hours ago 1

Hidden in mobile, Best for skyscrapers.